De novo design of potential RecA inhibitors using multi objective optimization

Area of Science:

• Computational chemistry
• Drug discovery
• Bioinformatics

Background:

• De novo ligand design requires optimizing multiple properties like binding affinity and drug likeness.
• Simultaneous optimization of these properties is crucial for efficient drug development.

Purpose of the Study:

• To model de novo ligand design as a multiobjective optimization problem.
• To evaluate the efficacy of Archived MultiObjective Simulated Annealing (AMOSA) for designing novel drug candidates.
• To identify potential inhibitors for the RecA protein of Mycobacterium tuberculosis.

Main Methods:

• Utilized Archived MultiObjective Simulated Annealing (AMOSA) for multiobjective ligand design.
• Incorporated energy components, similarity to known inhibitors, and a novel drug likeness measure (based on Lipinski's rule of five).
• Compared AMOSA's performance against LigBuilder, NEWLEAD, Variable Genetic Algorithm (VGA), and Nondominated Sorting Genetic Algorithm-II (NSGA-II).

Main Results:

• The proposed AMOSA approach successfully designed small molecules similar to known RecA inhibitors.
• Novel potential lead molecules targeting tuberculosis were discovered.
• Comparative analysis validated the efficacy of AMOSA against other established algorithms.

Conclusions:

• AMOSA is an effective algorithm for multiobjective de novo ligand design.
• The study identified promising novel candidates for anti-tuberculosis drug development.
• This approach advances the optimization of ligand properties for drug discovery.